HealthEquity Non Currrent Assets Other from 2010 to 2024

HQY Stock  USD 103.57  0.19  0.18%   
HealthEquity Non Currrent Assets Other yearly trend continues to be fairly stable with very little volatility. Non Currrent Assets Other are likely to outpace its year average in 2024. Non Currrent Assets Other is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. View All Fundamentals
 
Non Currrent Assets Other  
First Reported
2014-07-31
Previous Quarter
68.9 M
Current Value
65.4 M
Quarterly Volatility
23.1 M
 
Yuan Drop
 
Covid
Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.7 M, Interest Expense of 58.2 M or Selling General Administrative of 108.8 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0735 or PTB Ratio of 5.64. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.
  
Check out the analysis of HealthEquity Correlation against competitors.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Latest HealthEquity's Non Currrent Assets Other Growth Pattern

Below is the plot of the Non Currrent Assets Other of HealthEquity over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. HealthEquity's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HealthEquity's overall financial position and show how it may be relating to other accounts over time.
Non Currrent Assets Other10 Years Trend
Slightly volatile
   Non Currrent Assets Other   
       Timeline  

HealthEquity Non Currrent Assets Other Regression Statistics

Arithmetic Mean22,114,560
Coefficient Of Variation124.76
Mean Deviation24,125,072
Median2,180,000
Standard Deviation27,589,343
Sample Variance761.2T
Range73M
R-Value0.93
Mean Square Error109T
R-Squared0.87
Slope5,744,517
Total Sum of Squares10656.4T

HealthEquity Non Currrent Assets Other History

202471.3 M
202367.9 M
202252.2 M
202149.8 M
202037.4 M
201935.1 M
201821.1 M

About HealthEquity Financial Statements

HealthEquity investors use historical fundamental indicators, such as HealthEquity's Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Currrent Assets Other67.9 M71.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.